Anti-thrombomodulin antibodies and venous thrombosis
- 1 October 2004
- journal article
- Published by Wolters Kluwer Health in Blood Coagulation & Fibrinolysis
- Vol. 15 (7) , 553-558
- https://doi.org/10.1097/00001721-200409000-00004
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- Both Cellular and Soluble Forms of Thrombomodulin Inhibit Fibrinolysis by Potentiating the Activation of Thrombin-activable Fibrinolysis InhibitorJournal of Biological Chemistry, 1998
- The Thrombomodulin/Protein C/Protein S Anticoagulant Pathway Modulates the Thrombogenic Properties of the Normal Resting and Stimulated EndotheliumArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Postinfectious purpura fulminans caused by an autoantibody directed against protein SPublished by Elsevier ,1995
- Severe autoimmune protein S deficiency in a boy with idiopathic purpura fulminansBritish Journal of Haematology, 1995
- Antithrombotic effects of recombinant human soluble thrombomodulin (rhs‐TM) on arteriovenous shunt thrombosis in ratsAmerican Journal of Hematology, 1994
- Autoantibodies directed against the epidermal growth factor‐like domains of thrombomodulin inhibit protein C activation in vitroBritish Journal of Haematology, 1993
- Thrombomodulin, An Endothelial Anticoagulant; Its Structure, Function and Expression.Japanese Circulation Journal, 1992
- Intravenous recombinant soluble human thrombomodulin prevents venous thrombosis in a rat modelJournal of Vascular Surgery, 1991
- Recurrent Venous Thromboembolism in Patients with a Partial Deficiency of Protein SNew England Journal of Medicine, 1984
- Deficiency of protein C in congenital thrombotic disease.Journal of Clinical Investigation, 1981